A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

“The decision to know or not know your Alzheimer’s risk is deeply personal,” said Mozersky. “As we move into an era of ...

One of the fundamental barriers to equitable neurological care is the historic male bias in clinical research. For decades, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

The team used a special type of brain scan called tau PET, which tracks a protein known as tau that builds up in the brain ...